近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
2018年至今, 学术论文 (Selected Publications)
Wen Ding, Jianzheng Zhu, Jianshan Mo, Shumin Ouyang, Guopin Liu, Yingxue Su, Danyuan Sun, Jiangling Ye, Yanle Wu, Jiayu Yan, Menghan Xue, Peibin Yue, Jin-jian Lu, Libin Wang, Yandong Wang*, Xiaolei Zhang*. Neuropeptide Precursor VGF Promotes Neuroendocrine Differentiation and Cancer-Associated Fibroblast Activation in Small Cell Lung Cancer. Cancer Research, 2025 accepted (中科院一区，IF=16.6 )
Jingwei Li, Shumin Ouyang, Ziyou Lin, Keren Peng, Jiayu Yan, Minyuan Lu, Wen Ding, Jianshan Mo, Yingxue Su, Libin Wang, Peibin Yue, jinjian Lu, Xiangchao Yao, Yandong Wang, Xiaolei Zhang*. The IGF2BP3-FASN Axis Drives Lipid Metabolic Reprogramming to Promote Brain Colonization in Non-Small Cell Lung Cancer. Cell Death & Disease, 2025, 16:684 (中科院一区，IF=9.6 )
Wen Ding, Shuhao Liu, Wenjiang Liu,Zhijing Zhang,Jingyu Zhao, Xiaolei Zhang*, Taoda Shi*, Wenhao Hu*. Chirality-Guided Optimization of A2A Adenosine Receptor Antagonists for Enhanced Metabolic Stability and Antitumor Efficacy. J Med Chem, 2025, 68, 14962−14980 (中科院一区，IF=6.8 )
Wen Ding, Jianshan Mo, Yingxue Su, Qiyi Zhang, Danyuan Sun, Xiangchao Yao, Guopin Liu, Jiangling Ye, Yanle Wu, Menghan Xue, Peibin Yue, Jinjian Lu, Jian Zhang, Yanyu Shi, Wenhao Hu, Kai Zhu*, Yandong Wang*, Xiaolei Zhang*.Metabolic reprogramming of tumor-associated macrophages via adenosine-A2AR signaling drives cross-resistance in non-small cell lung cancer. Drug Resistance Updates 2025,82:101272（中科院一区 IF=21.7）
Ziyou Lin, Jingwei Li, Jian Zhang, Weineng Feng, Jiaye Lu, Xiaofan Ma, Wen Ding, Shumin Ouyang, Jinjian Lu, Peibin Yue, Guohui Wan, Peiqing Liu, Xiaolei Zhang*. Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR-TKIs in non-small lung cancer. Cancer Research. 2023 Jul 5;83(13):2187-2207. (中科院一区， IF=13.31 )
Shumin Ouyang, Shuo Shi, Wen Ding, Yang Ge, Yingxue Su, Jianshan Mo, Keren Peng, Qiyi Zhang, Guopin Liu, Wei Xiao, Peibin Yue, Jinjian Lu, Yandong Wang,* Xiaofeng Xiong,* and Xiaolei Zhang*. Neuropeptide Precursor VGF Promotes Liver Metastatic Colonization of G𝜶q Mutant Uveal Melanoma by Facilitating Tumor Microenvironment via Paracrine Loops. Advanced Science 2024, 2407967 (中科院一区， IF=14.30 )
Linlin Lou , Keren Peng, Shumin Ouyang, Wen Ding, Jianshan Mo, Jiayu Yan, Xiaoxiao Gong, Guopin Liu, Jinjian Lu, Peibin Yue, Kai Zhang, Jian Zhang*, Yan-Dong Wang*, Xiao-Lei Zhang*.Periostin‑mediated NOTCH1 activation between tumor cells and HSCs crosstalk promotes liver metastasis of small cell lung cancer. J Exp Clin Cancer Res. 2025 Jan 7;44(1):6 (中科院一区，IF=11.2)
Jianshan Mo, Lin Deng, Keren Peng, Shumin Ouyang, Wen Ding, Linlin Lou, Ziyou Lin, Jianzheng Zhu, Jingwei Li, Qiyi Zhang, Pengyan Wang, Yuanzhen Wen, Xiaobing Chen, Peibin Yue, JinJian Lu, Kai Zhu, Yongjiang Zheng*, Yuanxiang Wang*, Xiaolei Zhang *. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia. Journal of Hematology & Oncology. 2023 Feb 27;16(1):15. (中科院一区，IF=25.56)
Jiaye Lu, Jingwei Li, Ziyou Lin, Huaxuan Li, Linlin Lou, Wen Ding, Shumin Ouyang, Wu Yonghui, Yuanzhen Wen, Xiaobing Chen, Peibin Yue, Yuanxiang Wang, Jinjian Lu, Peiqing Liu, Jinjian Lu*,Jian Zhang*, Weineng Feng*, Xiaolei Zhang*. Reprogramming of TAMs by STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer. Cancer Letters. 2023 May 4;564:216205. (中科院一区，IF=9.67)
Pengyan Wang, Wen Ding, Jianshan Mo, Chenxi Gu, Shumin Ouyang, Keren Peng, Qiyi Zhang, Guopin Liu, Jinjian Lu, Yandong Wang, Wenhao Hu*, Kai Zhu*, Xiaolei Zhang*. A novel adenosine 2A receptor antagonist HZ-086 enhances the efficiency of immunotherapy and alleviates the acquired resistance to PD-L1 by restoration of T cell functions. Eur J Pharmacol. 2025 Jun 15:997:177535.
Zi-Han Ye, Wei-Bang Yu, Mu-Yang Huang, Yan-Yan Chen, Le-Le Zhang,Chung-Hang Leung, Xiao-Lei Zhang, Zhenghai Tang, Ting Li, and Jin-Jian Lu* Repurposing Cardiac Glycosides to Potentiate CD47Blockade through Calreticulin-mediated Phagocytic Effectsfor Lung Cancer Treatment. Advanced Science 2025, e08245 (中科院一区， IF=14.30 )
Tongfei Jin, Zhijing Zhang, Zhenghui Kang, Jianshan Mo, Xiaotong Yue, Ziyou Lin, Xiang Fu, Chang Liu, Hang Ma, Xiaolei Zhang*, Wenhao Hu*.Discovery and Optimization of Novel Biphenyl Derivatives BearingCyclopropyl Linkage as Potent Programmed Cell Death-1/ProgrammedCell Death-Ligand 1 Inhibitors. J Med Chem. 2023 May 25;66(10):6811-6835.. (中科院一区，IF=8.04 )
Shumin Ouyang, Huaxuan Li, Linlin Lou, Qiuyao Huang, Zhenhua Zhang, Jianshan Mo, Min Li, Jiaye Lu, Kai Zhu, Yunjie Chu, Wen Ding, Jianzheng Zhu, Ziyou Lin, Lin Zhong, Junjian Wang, Peibin Yue, James Turkson, Peiqing Liu*, Yuanxiang Wang*, Xiaolei Zhang*. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biology. 2022, (52) 102317 (中科院一区， IF=10.79 )
Yang Ge, Jun-Jie Deng, Jianzheng Zhu, Lu Liu, Shumin Ouyang, Zhendong Song, Xiaolei Zhang*, Xiao-Feng Xiong*, Discovery of small molecule Gαq/11 protein inhibitors against uveal melanoma, Acta Pharmaceutica Sinica B, 2022, Aug;12(8):3326-3340 (中科院一区，IF=14.90 )
Qiyi Zhang, Wen Ding, Jianshan Mo, Shumin Ouyang, Ziyou Lin, Keren Peng, Guopin Liu, Jinjian Lu, Peibin Yue, Jinping Lei, Yandong Wang*, Xiaolei Zhang*. Novel STAT3 Oligonucletide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma. Acta Pharmacol Sin. 2024 Aug;45(8):1701-1714 (中科院一区， IF=7.19)
Lin Deng, Jianshan Mo, Yi Zhang, Keren Peng, Huaxuan Li, Shumin Ouyang, Zongbo Feng, Wei Fang, Jianwei Wei, Deqin Rong, Xiaolei Zhang*, Yuanxiang Wang*. Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3. J Med Chem. 2022 Oct 13;65(19):13094-13111(中科院一区，IF=8.04 )
Shuhao Liu, Shuhao Liu, Wen Ding, Weifeng Huang, Zhijing Zhang, Yinfeng Guo, Qiyi Zhang, Linna Wu, Yukai Li, Rui Qin, Jiahao Li, Taoda Shi*, Xiaolei Zhang*, Jinping Lei*, and Wenhao Hu*. Discovery of Novel Benzo[4,5]imidazo[1,2-a]pyrazin-1-amine-3-amide-one Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists. J. Med. Chem. 2022, Jul 14;65(13):8933-8947 (中科院一区，IF=8.04 )
Huaxuan Li , Shumin Ouyang , Yi Zhang , Keren Peng , Wei Fang, Zhiqing Liu, Chang-Yun Wang , Xiaolei Zhang*, Yuanxiang Wang*. Structural optimization of Imidazo[1, 2-a]pyridine derivatives for the treatment of gastric cancer via STAT3 signaling pathway. Eur J Med Chem. 2022, 244,114858 (中科院一区， IF=7.09 )
Zhendong Song, Linlin Lou, Guangjin Fan, Lu Liu, Yang Ge, He Liu, Albert S.C. Chan, Xiaolei Zhang*, Xiaofeng Xiong*. Identification of Novel Pyrrolo[2,3-d]Pyrimidine-based KRAS G12C Inhibitors with Anticancer Effects. Eur J Med Chem. 2022, Nov 9th, doi.org/10.1016/ j.ejmech.2022.114907 (中科院一区， IF=7.09 )
Shumin Ouyang, Qiyi Zhang, Linlin Lou, Kai Zhu, Zeyu Li, Peiqin Liu*, Xiaolei Zhang*. The double-edged sword of SIRT3 in cancer and its therapeutic applications. Frontiers in Pharmacology, 2022, April 27th, (13):871560 ( 中科院二区，IF=5.99 )
Huanxin Xue, Jiaye Lu, Hongwei Yan, Ju Huang, Hai-Bin Luo, Man Shing Wong, Yuqi Gao*, Xiaolei Zhang*, Lei Guo*. γ-Glutamyl transpeptidase–activated indole-quinolinium based cyanine as a fluorescence turn-on nucleolus-targeting probe for cancer cell detection and inhibition. Talanta，2022 Jan 15;237:122898 (中科院二区， IF=6.56 )
Guangjin Fan, Linlin Lou, Zhendong Song*, Xiaolei Zhang*, Xiao-Feng Xiong*. Targeting mutated GTPase KRAS in tumor therapies. Eur J Med Chem. 2021; 226:113816 (中科院一区， IF=7.09 )
Yan Zhong, Lin Deng, Shuo Shi, Qiu-yao Huang, Shu-min Ou-Yang, Jian-shan Mo, Kai Zhu, Xin-ming Qu, Pei-qing Liu*, Yuan-xiang Wang* and Xiao-lei Zhang*.The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts. Acta Pharmacol Sin. 2022 Apr;43(4):1013-1023 (中科院一区， IF=7.19)
Qiuyao Huang, Yan Zhong, Bingbing Li, Shumin Ouyang, Lin Deng, Jianshan Mo, Shuo Shi, Nan Lv, Ruibo Wu, Peiqing Liu, Wenhao Hu, Xiaolei Zhang* Yuanxiang Wang*. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3). Eur J Med Chem. 2021;221:113525. (中科院一区， IF=7.09 )
Zheng Q, Dong H, Mo J, Zhang Y, Huang J, Ouyang S, Shi S, Zhu K, Qu X, Hu W, Liu P*, Wang Y*, Zhang X*. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance. Theranostics. 2021; 11(2):824-840. (中科院一区， IF=11.60 )
Yang Ge, Shuo Shi, Jun-Jie Deng, Xue-Ping Chen, Zhendong Song, Lu Liu, Linlin Lou, Xiaolei Zhang*, Xiao-Feng Xiong*.Design, Synthesis, and Evaluation of Small Molecule Gαq/11 Protein Inhibitors for the Treatment of Uveal Melanoma. J Med Chem. 2021,64(6):3131-3152. (中科院一区， IF=8.04 )
Xiao-lei Zhang#, Zhuo-ming Li#, Jian-tao Ye, Jing Lu, Lingyu Linda Ye, Chun-xiang Zhang, Pei-qing Liu* and Dayue D Duan*. Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives. Acta Pharmacol Sin. 2020 Nov; 41(11): 1377–1386. (中科院一区， IF=7.19 )
Qiuyao Huang, Yan Zhong, Hui Dong, Qiyao Zheng, Shuo Shi, Kai Zhu, Xinming, Wenhao Hu, Xiaolei Zhang*, Yuanxiang Wang*. Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go? Eur J Med Chem. 2020 ;187: 111922. (中科院一区， IF=7.09 )
Jingyan Li , Junying Huang, Jing Lu, Zhen Guo, Zhuoming Li, Hui Gao, Panxia Wang, Wenwei Luo, Sidong Cai, Yuehuai Hu, Kaiteng Guo, Luping Wang, Zhenzhen Li, Minghui Wang, Xiaolei Zhang*, Peiqing Liu*. Sirtuin 1 represses PKC-ζ activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy, British Journal of Pharmacology, 2019, 176(3):416-435 (中科院药学一区， IF=9.47 )
Lei Sun, Ruonian Liu, Zong-Jian Wu, Zheng-Yu Liu, Arabella H Wan, Shijia Yan, Chuwei Liu, Heng Liang, Min Xiao, Nan You, Yawen Lou, Yuan Deng, Xianzhang Bu, Dongshi Chen, Jun Huang, Xiaolei Zhang, Dong-Ming Kuang, Guohui Wan*. Gastroenterology . 2024 Mar;166(3):466-4824. (中科院一区， IF=16.60 )
张芷菁, 张启怡, 金祖翼, 朱凯, 丁文*, 张小雷*. 靶向腺苷A2A受体的肿瘤免疫治疗研究进展(Progress for targeting adenosine A2A receptors in cancer immunotherapy), 药学学报 Acta Pharmaceutica Sinica, 2022, 57(9):2557−2569
Ziyou Lin; Arabella H Wan; Lei Sun; Heng Liang; Yi Niu; Yuan Deng; Shijia Yan; Qiao-Ping Wang; Xianzhang Bu; Xiaolei Zhang; Kunhua Hu*; Guohui Wan*; Weiling He*. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Molecular Therapy, 2023 Feb 1;31(2):517-534 (中科院一区， IF=12.91 )
Wang B, Wan AH, Xu Y, Zhang RX, Zhao BC, Zhao XY, Shi YC, Zhang X, Xue Y, Luo Y, Deng Y, Neely GG, Wan G*, Wang QP*. Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity. Nat Commun. 2023 May 16;14(1):2241. (中科院一区， IF=16.60 )
Jian Li, Yang Ge, Junxiang Huang, Kristan Stromgaard, Xiaolei Zhang, Xiaofeng Xiong*. Heterotrimeric G Proteins as Therapeutic Targets in Drug Discovery. J Med Chem. 2020 May 28;63(10):5013-5030 (中科院一区，IF=8.04 )
Wenjing Yu, Yuehuai Hu, Zhiping Liu, Kaiteng Guo, Dinghu Ma, Mingxia Peng, Yuemei Wang , Jing Zhang, Xiaolei Zhang, Panxia Wang, Jiguo Zhang, Peiqing Liu*, Jing Lu*. Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis. Acta Pharm Sin B. 2023 Dec;13(12):4875-4892. (中科院一区，IF=14.90 )
石硕、朱凯、熊晓峰*、张小雷*。Gq 突变在葡萄膜黑色素瘤中的作用及其抑制剂研究进展 （Study of Gq mutations and their inhibitors in uveal melanoma）。药学学报 Acta Pharmaceutica Sinica 2020, 55(7): 1382 −1392
Mu-Yang Huang, Yu-Chi Chen, Wen-Yu Lyu, Xin-Yu He, Zi-Han Ye, Can-Yu Huang, Xin-Ling He, Xiuping Chen, Xiaobing Chen, Baoxian Zhang, Guoyin Kai, Xiaolei Zhang, Ting Li, Mingqing Huang, Jin-Jian Lu*. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10. Pharmacol Res. 2023 Dec:198:106988. ( 中科院药学一区，IF=9.30 )
Chun-Cao Xu, Yi-Fan Lin, Mu-Yang Huang, Xiao-Lei Zhang, Pei Wang, Ming-Qing Huang, Jin-Jian Lu*. Paraptosis: a non-classical paradigm of cell death for cancer therapy. Acta Pharmacol Sin. 2024 Feb;45(2):223-237.(中科院一区， IF=7.19 )
Yan-Ming Zhang, Ting Li , Chun-Cao Xu, Jia-Yu Qian, Hongwei Guo, Xiaolei Zhang, Zha-Jun Zhan*, Jin-Jian Lu*. Uncover the anticancer potential of lycorine. Chinese Medicine. 2024 Sep 8;19(1):121. （中科院医学二区， IF=5.32）
Jing Lu, Suowen Xu, Yuqing Huo, Duanping Sun, Yuehuai Hu, Junjian Wang, Xiaolei Zhang, Panxia Wang, Zhuoming Li, Mengya Liang, Zhongkai Wu*, Peiqing Liu*. Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3. Cell death and differentiation. 2021 Oct;28(10):2871-2887 (中科院一区， IF=15.83 )
Jianwei Zheng, Junfeng Wang, Qian Wang, Hongye Zou, Hong Wang, Zhenhua Zhang, Jianghe Chen, Qianqian Wang, Panxia Wang, Yueshan Zhao, Jing Lu, Xaiolei Zhang, Songtao Xiang, Haibin Wang, Jinping Lei, Hong-Wu Chen, Peiqing Liu, Yonghong Liu*, Fanghai Han*, Junjian Wang*. 2020 Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin, Acta Pharmaceutica Sinica B, 2020,10(12), 2313-2322 (中科院一区， IF=14.90 )
Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X, Sun L, Zhan S, Chen L, Cheng C, Zhang X, Bu X, He W*, Wan G*. RNA m6 A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. The EMBO Journal. 2020 Jun 17;39(12):e103181. (中科院一区， IF=14.01 )
Yuting Zhang, Weiting Lu, Xiaolei Zhang, Jing Lu, Suowen Xu, Shaorui Chen, Zhi Zhong, Ting Zhou, Quan Wang, Jianwen Chen*, Peiqing Liu*. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways. Pharmacol Res. 2019 Sep;147:104307 ( 中科院药学一区，IF=9.30 )
Michelle B. Trevino#, Xiaolei Zhang#, Robert A. Standley, Miao Wang,Xianlin Han, Felipe C. G. Reis, Muthu Periasamy, Gongxin Yu, Daniel P. Kelly, Bret H. Goodpaster,Rick B. Vega,1,2 and Paul M. Coen*.Loss of mitochondrial energetics is associated with poor recovery of muscle function but not mass following disuse atrophy. Am J Physiol Endocrinol Metab. 2019 Nov 1; 317(5): E899–E910.
Xiaoli Zhang, Trevino MB, Wang M, Gardell SJ, Ayala JE, Han X, Kelly DP, Goodpaster BH, Vega RB, Coen PM. Impaired Mitochondrial Energetics Characterize Poor Early Recovery of Muscle Mass Following Hind Limb Unloading in Old Mice, J Gerontol A Biol Sci Med Sci. 2018,73(10):1313-1322 (中科院一区， IF=6.59)
Stephen J Gardell, Xiaolei Zhang, Nidhi Kapoor, Christopher Petucci, Paul M Coen. Metabolomics Analyses of Muscle Atrophy Induced by Hind Limb Unloading. Methods Mol Biol. 2019;1996:297-309
Giovanna Distefano, Robert A. Standley, Xiaolei Zhang, Elvis A. Carnero, Fanchao Yi, Heather H. Cornnell, Paul M. Coen*. Physical activity unveils the relationship between mitochondrial energetics, muscle quality, and physical function in older adults. J Cachexia Sarcopenia Muscle. 2018 Apr; 9(2): 279–294. (中科院一区， IF=12.06 )
2018年之前，学术论文 （Selected Publications）
Xiaolei Zhang, Peibin Yue , Brent D.G. Page , Tianshu Li , Wei Zhao , Andrew T. Namanja , David Paladino , Jihe Zhao , Yuan Chen , Patrick T. Gunning , James Turkson . Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc. Natl. Acad. Sci. USA (PNAS) 2012, 109 (24): 9623-9628 (中科院一区， IF=12.78)
Zhang X, Blaskovich MA, Forinash KD, Sebti SM. Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours. British Journal of Cancer. 2014,111(5):894-902 (中科院一区， IF=9.07 )
Xiaolei Zhang, Ying Sun, Roberta Pireddu, Hua Yang, Murali K. Urlam , Harshani Lawrence , Wayne C. Guida , Nicholas J. Lawrence, Said M Sebti. A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation. Cancer Research 2013, 73(6):1922-1933 (中科院一区， IF=13.31 )
Teng P#, Zhang X#, Wu H, Qiao Q, Sebti SM, Cai J. Identification of novel inhibitors that disrupt STAT3-DNA interaction from a γ-AApeptide OBOC combinatorial library. Chem Commun (Camb). 2014 Aug 14;50(63):8739-42. (#Co-first Author) ( IF=6.22 )
Zhang X, Yue P, Fletcher S, Zhao W, Gunning PT, Turkson J. A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes. Biochem Pharmacol. 2010, 79(10):1398-409. ( IF=6.10)
Peibin Yue, Xiaolei Zhang, David Paladion, James Turkson. Hyperactive EGF receptor and Stat3 signaling promote enhanced colony-forming ability motility and migration of Cisplatin-resistant ovarian cancer cells. Oncogene 2012, 31(18):2309-22 (中科院一区， IF=8.76 )
Astha Malhotra, Xiaolei Zhang, James Turkson, Swadeshmukul Santra. Buffer-Stable Chitosan–Polyglutamic Acid Hybrid Nanoparticles for Biomedical Applications.Macromolecular Bioscience 2013 May;13(5):603-13 ( IF=5.86)
Awet Tecleab, Xiaolei Zhang and Said M. Sebti Ral GTPase down regulation stabilizes and reactivates p53 to inhibit malignant transformation. Journal of Biological Chemistry 2014 Nov 7;289(45):31296-309 ( IF=5.49)
Mitra, Rajendra; Doshi, Mona; Zhang, Xiaolei; Tyus, Jessica; Bengtsson, Niclas; Fletcher, Steven; Page, Brent; Turkson, James; Gesquiere, Andre; Gunning, Patrick; Walter, Glenn; Santra, Swadeshmukul. An activatable multimodal/multifunctional nanoprobe for direct imaging of intercellular drug delivery. Biomaterials. 2012, 33(5):1500-8 (中科院一区， IF=15.30 )
Fletcher S, Singh J, Zhang X, Yue P, Page BD, Sharmeen S, Shahani VM, Zhao W, Schimmer AD, Turkson J, Gunning PT. Disruption of transcriptionally active Stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities. Chembiochem. 2009, 10(12):1959-64 ( IF=3.46 )
京公网安备 11010802027423号